TrialBMC pulmonary medicine2017

Exploring efficacy and safety of oral Pirfenidone for progressive, non-IPF lung fibrosis (RELIEF) - a randomized, double-blind, placebo-controlled, parallel group, multi-center, phase II trial.

Jürgen Behr et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.